Link-Asia International MedTech Group Limited announces the following changes: Mr. Chak Chi Shing (``Mr. Chak'') has resigned as an independent non-executive Director and the chairman of the audit committee of the Company with effect from 23 September 2023 due to his own business commitment. Following Mr. Chak's resignation, Mr. Wu Chi King (``Mr. Wu'') has been appointed as the chairman of the audit committee of the Company and will cease to be the chairman of the remuneration committee but remain as a member of the remuneration committee with effect from 23 September 2023. Mr. Li Huiwu (``Mr Li'') will be appointed as the chairman of the remuneration committee.

Following the resignation of Mr. Chak, the Board comprises six members, including four executive Directors and two independent non-executive Director. The current number of independent non-executive Director is less than three as required under Rule 3.10(1) of the Listing Rules. Mr. Chak was also the chairman of the audit committee of the Company.

Following Mr. Chak's resignation, the Board is unable to fulfil the requirement of having three members on the audit committee under Rule 3.21 of the Listing Rules. The Company will ensure its compliance with the number and the composition of the independent non-executive Directors and the Board committees under the Listing Rules. The Company will make further announcement(s) as and when appropriate.